Internal Medicine, Cardiovascular Disease · Dothan, AL
NPI
1730173535
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4300 W Main St, Suite 102
Dothan, AL, 36305
Phone (334) 793-9564
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
1,802 services
Medicare patients, 2024
374
Average age 79
Drug cost, 2024
$951K
6,185 prescriptions
Company payments, 2025
$14.59
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher E Byard was code 93000 (electrocardiogram), 698 times for 371 patients. In total Christopher E Byard billed 1,802 services in 17 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 698 | 371 | $8.87 | $6,189 |
| 99213 Office E&M - Established | Office | 530 | 336 | $55.12 | $29K |
| 93793 Care Management/Coordination | Office | 340 | 21 | $7.16 | $2,434 |
| 99214 Office E&M - Established | Office | 152 | 125 | $82.04 | $12K |
| 93228 Electrocardiogram | Office | 18 | 18 | $18.39 | $331 |
| 71046 X-ray - Chest | Office | 11 | 11 | $18.86 | $208 |
By year: 2022 $66K for 2,219 services; 2023 $59K for 2,013 services; 2024 $53K for 1,802 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher E Byard prescribed most often to Medicare patients was Nebivolol Hcl, with 434 prescriptions and refills. In total Christopher E Byard wrote 6,185 Medicare prescriptions that cost $951K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nebivolol Hcl Generic | 434 | 975 | 119 | $29K |
| Nifedipine Er Nifedipine | 362 | 958 | 102 | $11K |
| Eliquis Apixaban | 308 | 594 | 72 | $337K |
| Valsartan Generic | 285 | 785 | 81 | $9,090 |
| Ezetimibe Generic | 271 | 711 | 71 | $6,411 |
| Carvedilol Generic | 268 | 716 | 74 | $2,301 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 261 | 707 | 72 | $13K |
| Rosuvastatin Calcium Generic | 245 | 687 | 70 | $3,833 |
| Atorvastatin Calcium Generic | 210 | 610 | 59 | $2,739 |
| Metoprolol Succinate Generic | 194 | 571 | 63 | $3,623 |
| Clopidogrel Clopidogrel Bisulfate | 188 | 557 | 55 | $2,111 |
| Hydrochlorothiazide Generic | 162 | 423 | 58 | $959 |
| Amlodipine Besylate Generic | 160 | 420 | 53 | $996 |
| Entresto Sacubitril/Valsartan | 121 | 191 | 23 | $124K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 119 | 309 | 30 | $1,909 |
Brand drugs: 865 claims; generic drugs: 5,320 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher E Byard $14.59 ($14.59 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $14.59.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $14.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.